179 related articles for article (PubMed ID: 21914252)
1. Cognitive therapy for people with a schizophrenia spectrum diagnosis not taking antipsychotic medication: an exploratory trial.
Morrison AP; Hutton P; Wardle M; Spencer H; Barratt S; Brabban A; Callcott P; Christodoulides T; Dudley R; French P; Lumley V; Tai SJ; Turkington D
Psychol Med; 2012 May; 42(5):1049-56. PubMed ID: 21914252
[TBL] [Abstract][Full Text] [Related]
2. Metacognitive therapy in people with a schizophrenia spectrum diagnosis and medication resistant symptoms: a feasibility study.
Morrison AP; Pyle M; Chapman N; French P; Parker SK; Wells A
J Behav Ther Exp Psychiatry; 2014 Jun; 45(2):280-4. PubMed ID: 24440585
[TBL] [Abstract][Full Text] [Related]
3. A preliminary exploration of predictors of outcome and cognitive mechanisms of change in cognitive behaviour therapy for psychosis in people not taking antipsychotic medication.
Morrison AP; Turkington D; Wardle M; Spencer H; Barratt S; Dudley R; Brabban A; Hutton P
Behav Res Ther; 2012 Feb; 50(2):163-7. PubMed ID: 22209267
[TBL] [Abstract][Full Text] [Related]
4. High-yield cognitive behavioral techniques for psychosis delivered by case managers to their clients with persistent psychotic symptoms: an exploratory trial.
Turkington D; Munetz M; Pelton J; Montesano V; Sivec H; Nausheen B; Kingdon D
J Nerv Ment Dis; 2014 Jan; 202(1):30-4. PubMed ID: 24375209
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic treatment beyond antipsychotics: metacognitive intervention for schizophrenia patients improves delusional symptoms.
Moritz S; Veckenstedt R; Randjbar S; Vitzthum F; Woodward TS
Psychol Med; 2011 Sep; 41(9):1823-32. PubMed ID: 21275083
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia.
Grant PM; Huh GA; Perivoliotis D; Stolar NM; Beck AT
Arch Gen Psychiatry; 2012 Feb; 69(2):121-7. PubMed ID: 21969420
[TBL] [Abstract][Full Text] [Related]
7. An exploratory, randomized controlled trial of adherence therapy for people with schizophrenia.
Anderson KH; Ford S; Robson D; Cassis J; Rodrigues C; Gray R
Int J Ment Health Nurs; 2010 Oct; 19(5):340-9. PubMed ID: 20887608
[TBL] [Abstract][Full Text] [Related]
8. Cognitive behaviour therapy in patients with schizophrenia who are not prescribed antipsychotic medication: a case series.
Christodoulides T; Dudley R; Brown S; Turkington D; Beck AT
Psychol Psychother; 2008 Jun; 81(Pt 2):199-207. PubMed ID: 18230197
[TBL] [Abstract][Full Text] [Related]
9. Acute-phase and 1-year follow-up results of a randomized controlled trial of CBT versus Befriending for first-episode psychosis: the ACE project.
Jackson HJ; McGorry PD; Killackey E; Bendall S; Allott K; Dudgeon P; Gleeson J; Johnson T; Harrigan S
Psychol Med; 2008 May; 38(5):725-35. PubMed ID: 18005494
[TBL] [Abstract][Full Text] [Related]
10. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.
Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R
Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765
[TBL] [Abstract][Full Text] [Related]
11. Sustained and "sleeper" effects of group metacognitive training for schizophrenia: a randomized clinical trial.
Moritz S; Veckenstedt R; Andreou C; Bohn F; Hottenrott B; Leighton L; Köther U; Woodward TS; Treszl A; Menon M; Schneider BC; Pfueller U; Roesch-Ely D
JAMA Psychiatry; 2014 Oct; 71(10):1103-11. PubMed ID: 25103718
[TBL] [Abstract][Full Text] [Related]
12. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R
Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
[TBL] [Abstract][Full Text] [Related]
13. Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk.
Morrison AP; French P; Parker S; Roberts M; Stevens H; Bentall RP; Lewis SW
Schizophr Bull; 2007 May; 33(3):682-7. PubMed ID: 16973786
[TBL] [Abstract][Full Text] [Related]
14. Befriending patients with medication-resistant schizophrenia: can psychotic symptoms predict treatment response?
Samarasekera N; Kingdon D; Siddle R; O'Carroll M; Scott JL; Sensky T; Barnes TR; Turkington D
Psychol Psychother; 2007 Mar; 80(Pt 1):97-106. PubMed ID: 17346383
[TBL] [Abstract][Full Text] [Related]
15. An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand.
Maneesakorn S; Robson D; Gournay K; Gray R
J Clin Nurs; 2007 Jul; 16(7):1302-12. PubMed ID: 17584349
[TBL] [Abstract][Full Text] [Related]
16. Cognitive behaviour therapy for schizophrenia: relationship between anxiety symptoms and therapy.
Naeem F; Kingdon D; Turkington D
Psychol Psychother; 2006 Jun; 79(Pt 2):153-64. PubMed ID: 16774715
[TBL] [Abstract][Full Text] [Related]
17. Complementary group Metacognitive Training (MCT) reduces delusional ideation in schizophrenia.
Moritz S; Veckenstedt R; Bohn F; Hottenrott B; Scheu F; Randjbar S; Aghotor J; Köther U; Woodward TS; Treszl A; Andreou C; Pfueller U; Roesch-Ely D
Schizophr Res; 2013 Dec; 151(1-3):61-9. PubMed ID: 24183707
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
Citrome L; Meng X; Hochfeld M; Stahl SM
Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
[TBL] [Abstract][Full Text] [Related]
19. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
20. The temporal relationship between symptom change and treatment discontinuation in a pooled analysis of 4 schizophrenia trials.
Kinon BJ; Ascher-Svanum H; Adams DH; Chen L
J Clin Psychopharmacol; 2008 Oct; 28(5):544-9. PubMed ID: 18794651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
